Combination therapy - Recommendations for severe onychomycosis;Terapia skojarzona - Zalecane leczenie ciȩżkich postaci grzybicy paznokci

Mikologia Lekarska

Volumn 10, Issue 2, 2003, Pages 75-78

  Baran, Eugeniusz ^a   Adamski, Zygmunt ^b   Maleszka, Romuald ^c   Szepietowski, Jacek ^a   Nowicki, Roman ^d  

^a Kat/Klin Dermatol   (Poland)

^b Katedra i Klinika Dermatologii   (Poland)

^c Katedro Klin Chorob Skornych W P   (Poland)

^d NONE

Author keywords

Amorolfine; Ciclopiroxolamine; Combination therapy; Fluconazole; Itraconazole; Onychomycosis; Pentoxiphyline; Terbinafine

Indexed keywords

AMOROLFINE; CICLOPIROXOLAMINE; FLUCONAZOLE; ITRACONAZOLE; PENTOXIFYLLINE; TERBINAFINE;

DISEASE SEVERITY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; MONOTHERAPY; ONYCHOMYCOSIS; PATIENT ATTITUDE; REVIEW; TREATMENT OUTCOME;

EID: 0037573446     PISSN: 1232986X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Baran R., Hay R.J.: New evidence for the efficacy of combination therapy in onychomycosis. Br. J. Dermatol. 2001, 145 (Suppl. 60), 1.
2. Elewski B.E.: A full 'cure' of onychomycosis is not always possible. Arch. Dermatol. 1999, 135, 852-853.
3. Epstein E.: How often does oral treatment of toenail onychomycosis produce a desease-free nail? An analysis of published data. Arch. Dermatol., 1998, 134, 1551-1554.
4. Szepietowski J., Rózycka B.: Skojarzona terapia grzybicy paznokci. Mikol. Lek. 2001, 8, 47-54.
5. Glinski W., Baran E., Nowicki R., Maleszka R., Adamski Z., Kaszuba A.: Konsensus dotycza̧cy leczenia powierzchownych zakażeń grzybiczych. Przegl. Dermatol., 2002, 89, 85-92.
6. Tosti A., Piraccini B., Stinchi C., Venturo N., Bardazzi F., Colombo MD.: Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J. Am. Acad. Dermatol., 1996, 34, 595-600.
7. Evans E.G.V., Sigurgeirsson B.: Double blind, randomized study of continuous terbinafine compared with intermittent itraconazole in treatment of onychomycosis. BMJ, 1999, 318, 1031-1035.
8. FDA Public Health Advisory: The safety of Sporanox capsules and Lamisil tablets for the treatment of onychomycosis. 9 maja 2001.
9. Gupta A.K., Baran R., Summerbell R.; Onychomycosis: strategies to improve efficacy and reduce recurrence. JEADV, 2002, 16, 579-586.
10. Ratajczak-Stefańska V., Maleszka R.: Kliniczne i mikologiczne aspekty nawrotowej grzybicy paznokci. Mikol. Lek., 2003, 10.
11. Meinhof W., Girardi R., Stracke A.: Patient noncompliance in dermatomycosis. Results of a survey among dermatologists and general practitioners and patients. Dermatologica, 1984, 169 (Suppl. 1) 57-66.
12. Gupta A.K., Lynde C.W., Konnikov N.: Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J. Am. Acad. Dermatol., 2000, 44, 485-491.
13. Maleszka R., Adamski Z.: Leczenie rozległel grzybicy dermatofitowej paznokci u pacjentów w starszym wieku. Wiad. Parazytol., 2001, 47 (Suppl. 4), 817-822.
14. Baran E., Bocheński J., Duczkowski M., Baran W.: Terapia skojarzona grzybicy paznokci amorolfina̧ w lakierze i doustnymi lekami przeciwgrzybiczymi. Mikol. Lek., 2003, 10, 79-83.
15. Baran R., Feuilhade M., Combernale P., Dafry A., Goettmann S., Pietrini P., Viquie C., Badillet G., Lanier C., Czernielewski J.: A randomized trail of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment dermatophytic toenail onychomycosis affecting the matrix region. Br. J. Dermatol., 2000, 142, 1177-1183.
16. Lecha M.: Amorolfine and itraconazole combination for severe toenail onychomycosis: results of an open randomized trial in Spain. Br. J. Dermatol., 2001, 145 (Suppl. 60), 21-26.
17. Nolting S.: Open studies of cicolpirox nail lacquer in onychomycosis - a review. [w:] Shuster S. (red.). Hydroxypyridones as Antifungal Agents with Special Emphasis on Onychomycosis. Springer-Verlag, Berlin, 1999, 75-80.
18. Maleszka R., Ratka P., Lis M.: Evaluation of symptoms and mycotic tests in subjects with recerrent onychomycosis. Mikol. Lek., 1997, 4, 161-165.
19. Polak A.M.: Kinetics of amorolfine in human nails. Mycoses 1993, 36, 101-103.
20. Maleszka R., Ratajczak V., Turek-Krasinska K., Gła̧bowska D.: Zastosowanie amorolfiny w leczeniu grzybicy dermatofitowej paznokci. Przegl. Dermatol., 2002, 89, 493-496.